Abcam
Abcam’s aim is to serve life science researchers to achieve their mission, faster. We continuously listen, collaborate and support the scientific community in order to improve and offer new affinity binders, reagents, biomarkers and assays that will drive greater scientific progress.
Our culture is a key differentiator. We believe in empowering individuals, with responsibility given at an early stage. The working environment is fun and fast-paced, collaborative and outcome focused, with a strong customer focus. In addition to competitive salaries we offer an attractive flexible benefits package with plenty of opportunities to learn and grow.
Our head office is in Cambridge (UK), we also have offices in Bristol (UK), Cambridge, Eugene and San Francisco (USA), Tokyo (Japan), Hong Kong, Hangzhou and Shanghai (China).
We have a range of roles in IT background and would normally look for candidates with a degree in computer science or other numerate disciplines. We also recruit positions for candidates with a scientific background and we would normally look for candidates with biological science qualifications.
Show more| Type | Public |
| HQ | Milton, GB |
| Founded | 1998 |
| Size (employees) | 948 (est)+8% |
| Website | abcam.com |
Abcam was founded in 1998 and is headquartered in Milton, GB
Report incorrect company information
Viewing summary data as a guest
Sign up for free to see all dataKey People/Management at Abcam
Jonathan Milner
CEO
Report incorrect company information
Abcam Office Locations
Abcam has offices in San Francisco, Eugene, Tokyo, Milton and in 8 other locations
Milton, GB (HQ)
330 Cambridge Science Park Milton Rd
Cambridge, US (HQ)
b2304 One Kendall Square Binney St
Shanghai, CN
Galileo Rd. Pudong
Tokyo, JP
2-2-1 Nihonbashi Horidome-cho
Cambridge, US
b2304 1 Kendall Square
Report incorrect company information
Abcam Financials and Metrics
Abcam Revenue
Abcam's revenue was reported to be £217.10 m in FY, 2017
| GBP | |
|---|---|
Revenue (FY, 2017) | 217.1m |
Gross profit (FY, 2017) | 152.1m |
Gross profit margin (FY, 2017), % | 70.1% |
Net income (FY, 2017) | 42.4m |
EBITDA (FY, 2017) | 70.5m |
EBIT (FY, 2017) | 55.1m |
Cash (30-Jun-2017) | 84.8m |
| GBP | FY, 2000 | FY, 2001 | FY, 2002 | FY, 2003 | FY, 2004 | FY, 2005 | FY, 2006 | FY, 2007 | FY, 2008 | FY, 2009 | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 248.4k | 719.6k | 1.8m | 3.5m | 6.7m | 12.1m | 19.4m | 24.5m | 36.7m | 56.8m | 71.1m | 83.3m | 97.8m | 122.2m | 128.0m | 144.0m | 171.7m | 217.1m |
Revenue growth, % | 13% | 19% | ||||||||||||||||
Cost of goods sold | 160.4k | 416.1k | 820.6k | 1.4m | 2.5m | 4.7m | 7.5m | 10.0m | 14.4m | 19.4m | 23.7m | 27.2m | 30.3m | 35.5m | 37.6m | 42.5m | 51.1m | 65.0m |
Gross profit | 88.0k | 303.5k | 983.7k | 2.1m | 4.2m | 7.5m | 11.9m | 14.5m | 22.3m | 37.4m | 47.4m | 56.0m | 67.6m | 86.7m | 90.4m | 101.5m | 120.5m | 152.1m |
| GBP | FY, 1999 | FY, 2000 | FY, 2001 | FY, 2002 | FY, 2003 | FY, 2004 | FY, 2005 | FY, 2006 | FY, 2007 | FY, 2008 | FY, 2009 | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 9.6k | 269.1k | 87.3k | 59.1k | 66.1k | 274.3k | 510.0k | 884.0k | 2.2m | 13.5m | 25.5m | 40.2m | 55.6m | 14.0m | 37.3m | 55.3m | 57.1m | 68.9m | 84.8m |
Accounts Receivable | 55.1k | 158.6k | 261.0k | 424.8k | 926.8k | 1.7m | 2.4m | 3.3m | 3.7m | 5.4m | 6.8m | 7.9m | 11.5m | 12.1m | 13.2m | 19.6m | |||
Inventories | 3.2k | 4.0k | 18.1k | 69.4k | 185.9k | 557.8k | 1.2m | 2.4m | 3.1m | 4.5m | 6.8m | 9.1m | 10.7m | 15.4m | 15.3m | 14.8m | 19.8m | 19.7m | 21.8m |
Current Assets | 33.6k | 362.3k | 320.8k | 696.5k | 864.3k | 2.7m | 4.6m | 17.0m | 18.1m | 23.9m | 40.1m | 58.5m | 76.4m | 48.7m | 71.3m | 90.9m | 100.5m | 119.7m | 143.5m |
| GBP | FY, 2000 | FY, 2001 | FY, 2002 | FY, 2003 | FY, 2004 | FY, 2005 | FY, 2006 | FY, 2007 | FY, 2008 | FY, 2009 | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (190.1k) | (471.9k) | (328.2k) | 517.2k | 1.0m | 2.3m | 3.7m | 4.1m | 5.9m | 12.3m | 19.2m | 23.8m | 25.4m | 32.7m | 34.0m | 37.4m | 37.4m | 42.4m |
Cash From Operating Activities | 2.6m | 3.5m | 4.9m | 7.1m | 14.8m | 19.7m | 25.5m | 24.5m | 39.4m | 41.3m | 40.2m | 47.3m | 66.4m | |||||
Dividends Paid | 300.0k | 1.3m | 1.2m | 968.0k | 2.6m | 5.3m | 7.9m | 10.1m | 12.5m | 11.3m | 15.9m | 16.7m | 19.1m | |||||
Cash From Financing Activities | 570.0k | 9.3m | 47.0k | (2.2m) | (1.2m) | (27.4m) | (7.6m) | 10.7m | (11.8m) | (13.8m) | (14.1m) | (15.4m) | (17.7m) |
| GBP | Y, 2017 |
|---|---|
Revenue/Employee | 237.3k |
Financial Leverage | 1.2 x |
Report incorrect company information
Abcam Online and Social Media Presence
5.41k Twitter followers
Abcam has 5.41k Twitter Followers. The number of followers has increased 1.7% month over month and increased 4.1% quarter over quarter
11.14k Facebook likes
Abcam has 11.14k Facebook Likes. The number of likes has increased 1.8% month over month and increased 7.1% quarter over quarter
Report incorrect company information
Abcam News and Updates
July 23, 2018
Alpha-lactalbumin Market : Industry Perspective and Comprehensive Analysis 2024
Persistence Market Research has announced the addition of the “Alpha-lactalbumin Market: Global Industry Analysis and Opportunity Assessment 2016 - 2024" report to their offering. Posted via Industry Today. Follow us on Twitter @IndustryToday
July 20, 2018
Future of Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market including key players Abcam, BD, bioMerieux, Bio-Rad Laboratories
Enzyme-linked immunosorbent assay (ELISA) is mainly used to measure antibodies, antigens, proteins, and glycoproteins in biological samples. Posted via Industry Today. Follow us on Twitter @IndustryToday
June 25, 2018
Antibodies Global Market 2018: Key Players – Abcam PLC, Abnova, Active Motif, Agilent Technologies, BD Biosciences, Beckman Coulter Inc.
Antibodies -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023 Posted via Industry Today. Follow us on Twitter @IndustryToday
May 28, 2018
UPDATE 1-Brazil truckers association Abcam recommends end of strike
SAO PAULO, May 28 (Reuters) - A Brazilian truckers
association behind a week-long nationwide fuel-price protest
that paralyzed key sectors of Latin America's biggest economy
told drivers to get back to work on Monday after the government
caved in to their demands.
April 10, 2018
Protein Assays Market 10.8% of CAGR Expected by 2023 with Abcam plc, Lucigen Co, QIAGEN, Illumina Inc, Takara Bio Inc
Protein Assays Market Research Report– by Type (Copper-Ion-Based Assays, Test Strip-Based Assays, and Dye-Binding Assays), By Application (Diagnosis, Drug Discovery, and Protein Purification), By Product, By Technology, and By End User– Global forecast till 2023 Posted via Industry Today. Follow us …
January 17, 2018
Monoclonal Antibody Custom Service Market Accruals of Tremendous Growth by 2023 At 10.84% of CAGR
Monoclonal Antibody Custom Service Market provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information
Abcam Blogs
September 27, 2018
The Social Scientist
I think it’s safe to say that all of us, at some point or another, have struggled with “networking.” Let’s face it: as scientists, we often work in isolation and so meeting the right people to discuss work or even collaborate with, can be challenging. It’s also incredibly awkward for a lot of us! Th…
September 20, 2018
BioRxiv: give pre-prints a chance
How can BioRxiv benefit me? The question many life scientists are asking themselves. For those that don’t know, BioRxiv (pronounced “bio-archive”) is a pre-print service where you can publish any life science article without going through the peer-review process. The concept of pre-prints is by no m…
September 14, 2018
Why I love communicating my science – and why you should too
Discovering the world of scicomm Although I started my PhD with an unwavering passion and bright-eyed enthusiasm for research, about halfway in to my PhD there felt like there was something missing. I was a student with a single focus – my PhD. As a young scientist with a variety of experience, I wa…
September 06, 2018
Behind the research: why scientists do what they do
What drives a scientist to do their research? We wanted to know why you guys do what you do? What makes a scientist get out of bed in the morning, go to the lab, and do their research. So we asked you! We carried out a survey asking scientists a whole bunch of questions to understand […]
The post Be…
September 05, 2018
#scicomm: is it your duty to communicate your research?
Hurrah! We’re going to be hosting our first event! Scicomms has ballooned over past couple of years and we’ve been following the process. Thousands of scientists, young and old, sharing what they’re doing in the lab; posting all the problems and elation they encounter. The feeds of Instagram and Twi…
August 23, 2018
10 tips for mentoring an undergrad in the lab
It’s true – undergraduate students don’t exactly have the best reputation around research labs. But, as a former undergrad researcher (and now PhD student) myself, I’ve found that a little mentoring can go a long way. Throughout my journey, I’ve picked up a few lessons that have been helpful in advi…
Abcam Company Life and Culture
Report incorrect company information